Amarin Corp Plc (AMRN)

[lettruthringout]

Probably no China approval ...

... before Edding IPO is complete and Edding listed on HKEX. Government in cahoots with pharmaceutical companies and Edding needs to raise money before launch. Bad news is Hong Kong IPOs moving very slowly this year. Good news is that after an initial false start, Edding just re-submitted.
-----------------------------------------------------
On December 17, Capital State learned that Eton Pharmaceuticals submitted a prospectus to the Hong Kong Stock Exchange and planned to be listed on the Hong Kong Main Board IPO. The company previously submitted the prospectus twice on September 23, 2020 and March 29, 2021, and then passed the hearing of the Hong Kong Stock Exchange on June 25, 2021. The prospectus was invalidated after the IPO was not initiated.

https://www.sohu.com/a/509308618_223785
--------------------------------------------------------------

Fat cats in the mainland can just slip over to Hainan to get their Vascepa. It recently got easier to get prescriptions there.

-----------------------------------------------------

15:08, November 25, 2021 Source: Nanhai Net

Xin Hainan Client, Nanhai Net, Nanguo Metropolis Daily News on November 24 (Reporter Su Guizu) The reporter learned from the Lecheng Pioneer District Administration that the Hainan Provincial Drug Administration recently approved the approval of the Boao Lecheng Pioneer District. Life Care Center, licensed clinical application for batch application of 300 bottles (120 tablets/bottle) of imported drug Icosapent ethyl (VASCEPA®) urgently needed.

According to the spirit of the relevant documents, the clinically urgently needed imported drugs (excluding vaccines) and medical devices to be used in the Lecheng Pilot Zone can be stored in batches in the bonded drug warehouses in the Lecheng Pilot Zone before approval. After the medical institution obtains the approval for the use of urgently needed drugs from the drug regulatory department, the imported drugs urgently needed for clinical use can be cleared out of the warehouse in batches and distributed to the medical institution for use.

The 300 bottles approved this time, totaling 36,000 Icosapent ethyl (VASCEPA®) licensed drugs, are the results of institutional innovation by the relevant departments of Hainan Province to further simplify the approval process of clinically urgently needed imported drugs and optimize the approval model.

After the batch application of medical institutions is approved by the Hainan Provincial Food and Drug Administration, doctors can prescribe urgently needed clinically imported drugs for patients to use according to the needs of patients and under standardized use standards.

This benefit has also further optimized the "Bring medicine and leave the park" policy in the Lecheng Pioneer Zone. After the patient is discharged from the hospital with medicines, there is no need to record real-time video and upload it to the imported medical equipment traceability system of Lecheng Pioneer District every time a medicine is taken. It only needs to feed back the first, intermediate and last medication records to the medical institution, which truly simplifies the medication process for patients with chronic diseases. , Bring convenience for the long-term medication of patients with chronic diseases.

Yue Hongwen, director of the Boao Yiling Cardiovascular and Metabolism Medicine Center, said that the batch approval policy has brought great convenience to patients and medical institutions. Medical institutions can use it for patients according to clinical needs, and are no longer subject to the restriction of one person, one medicine. The efficiency will be greatly improved, and it will truly realize the benefits of letting patients wait for medicines.

http://www.hi.chinanews.com.cn/hnnew/2021-11-25/613568.html

----------------------------------------------------------